SARS CoV 2 News and Research

RSS

Could creatine supplementation be the answer to post-COVID-19 fatigue?

In a recent study published in the journal Food Science & Nutrition, researchers investigated creatine supplementations as a potential intervention strategy to attenuate the clinical symptoms of post-COVID-19 fatigue syndrome.

22 Sep 2023

Can COVID-19 vaccines turn the tide on long-haul symptoms?

The study finds that COVID-19 vaccination can significantly reduce symptoms and improve well-being in patients suffering from post-COVID-19 conditions (PCC). Vaccination also lowered systemic markers of inflammation but did not entirely eliminate persistent SARS-CoV-2 antigens, which may continue to contribute to inflammation.

22 Sep 2023

Inhaled fluticasone furoate falls flat in speeding up COVID-19 recovery, says ACTIV-6 trial

The ACTIV-6 trial investigated the effectiveness of inhaled fluticasone furoate on mild-to-moderate COVID-19 cases and found it did not accelerate recovery or prevent clinical progression compared to a placebo. Interestingly, vaccinated participants showed slightly faster recovery when treated with the drug, while unvaccinated participants did not.

21 Sep 2023

Cough analysis as a tool to predict severe pneumonia in COVID-19 patients

While most individuals impacted by COVID-19 experience milder symptoms and recover within a few weeks, the global pandemic caused by the SARS-CoV-2 virus continues to pose a significant health challenge.

21 Sep 2023

Unlocking the power of mRNA vaccines: From COVID-19 to cancer and beyond

A comprehensive review in Signal Transduction and Targeted Therapy delves into the versatility and effectiveness of mRNA vaccines, from their game-changing role in COVID-19 to potential applications in cancer and rare diseases. Despite drawbacks like stability and high immunogenicity, advancements in vaccine technology have poised mRNA platforms as a robust tool for both preventive and therapeutic interventions.

21 Sep 2023

Cornell researchers receive NIH grant to launch new center for developing point-of-care diagnostic devices

An interdisciplinary team led by Cornell has received a five-year grant to launch a new center for engineering, testing and commercializing point-of-care diagnostic devices that will have international reach.

21 Sep 2023

Study offers new insight into immune cells critical to successful vaccination against SARS-CoV-2

A study has revealed new details about a key population of immune system cells critical to successful vaccination against the pandemic virus, SARS-CoV-2.

21 Sep 2023

Has the COVID-19 pandemic made young adults less fit?

A recent study in Scientific Reports reveals that one year after the onset of the COVID-19 pandemic, young adults experienced significant declines in physical fitness parameters, including explosive power, aerobic and anaerobic capacities, and weight. These changes could have serious health implications, especially for those with diabetes and cardiovascular diseases, underscoring the importance of promoting physical activity during and after pandemics.

20 Sep 2023

Nanotechnology-based strategies for preventing, treating, and diagnosing viral infections

Newly emerging and recurrent cases of viral infections constitute a significant problem and a huge challenge to public health.

20 Sep 2023

Early treatment with convalescent plasma may reduce risk of long COVID

Findings from a nationwide, multicenter study led by Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health suggest that patients with COVID-19 have less chance of developing post-COVID conditions -; commonly known as long COVID -; if they receive early treatment with plasma from convalescent (recovered) COVID patients that contain antibodies against SARS-CoV-2, the virus that causes COVID-19.

20 Sep 2023

Study identifies a molecule that may be behind COVID-19 brain fog

A study identifies a molecule that may be behind cognitive symptoms, including "brain fog," experienced by those infected by the SARS-CoV-2 virus.

20 Sep 2023

Vaccine impact: BNT162b2 and pediatric COVID-19 ambulatory visits in kids under 5

The association between BNT162b2 vaccine and (COVID-19)-related ambulatory visits.

20 Sep 2023

Innovations in baculovirus–insect cell expression systems

The baculovirus–insect cell expression system—insect cells used in conjunction with the baculovirus expression vector system (BEVS)— remains a crucial technology for manufacturing large and complex proteins. This eukaryotic expression system offers inherent safety, ease of scale-up, flexible product design, and versatility for a broad range of proteins.

From Sino Biological Inc. 20 Sep 2023

Cancer drug could play a role in limiting the damaging effects of lung disease in COVID-19 patients

A cancer drug could play an important role in limiting the damaging effects of lung disease in COVID-19 patients, thanks to new research at Hudson Institute of Medical Research.

19 Sep 2023

Health workers warn loosening mask advice in hospitals would harm patients and providers

Nurses, researchers, and workplace safety officers worry new guidelines from the Centers for Disease Control and Prevention might reduce protection against the coronavirus and other airborne pathogens in hospitals.

18 Sep 2023

How did exposure to news on COVID-19 through social platforms impact psychological health and behavior?

The relationship between news on the COVID-19 pandemic through social media, feelings of fear and anxiety, and behavior.

18 Sep 2023

Is the new bivalent COVID-19 vaccine the booster we've been waiting for?

The bivalent COVID-19 vaccine developed by GSK and Sanofi shows promising results with a 64.7% overall effectiveness against symptomatic COVID-19, according to a phase 3 trial. The vaccine performs especially well as a booster, achieving 75.9% efficacy in non-naïve subjects.

17 Sep 2023

How well do current vaccines hold up against new SARS-CoV-2 variants BA.2.86 and FLip?

The study explores the efficacy of three-dose monovalent or bivalent vaccinations in neutralizing newly emerged SARS-CoV-2 variants BA.2.86 and FLip. While BA.2.86 showed lower immune evasion abilities compared to recent XBB variants, it was less effectively neutralized by the monoclonal antibody S309, raising questions about vaccine efficacy against evolving strains.

17 Sep 2023

Phase 3 study: The efficacy of monovalent SARS-CoV-2 vaccine with AS03 adjuvant in adults

The effectiveness of a novel monovalent recombinant protein vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

15 Sep 2023

Unlocking the power of lectins: BOA emerges as a potent weapon against all SARS-CoV-2 variants

Researchers discover that antiviral lectins like BOA can effectively inhibit SARS-CoV-2 and its variants by targeting spike glycans, opening doors for potential pan-coronavirus treatments. The study reveals that BOA's multivalent interactions make it a potent inhibitor against a range of viral variants, offering promise for future therapeutic strategies.

14 Sep 2023

SARS CoV 2 News and Research

Could creatine supplementation be the answer to post-COVID-19 fatigue?

Can COVID-19 vaccines turn the tide on long-haul symptoms?

Inhaled fluticasone furoate falls flat in speeding up COVID-19 recovery, says ACTIV-6 trial

Cough analysis as a tool to predict severe pneumonia in COVID-19 patients

Unlocking the power of mRNA vaccines: From COVID-19 to cancer and beyond

Cornell researchers receive NIH grant to launch new center for developing point-of-care diagnostic devices

Study offers new insight into immune cells critical to successful vaccination against SARS-CoV-2

Has the COVID-19 pandemic made young adults less fit?

Nanotechnology-based strategies for preventing, treating, and diagnosing viral infections

Early treatment with convalescent plasma may reduce risk of long COVID

Study identifies a molecule that may be behind COVID-19 brain fog

Vaccine impact: BNT162b2 and pediatric COVID-19 ambulatory visits in kids under 5

Innovations in baculovirus–insect cell expression systems

Cancer drug could play a role in limiting the damaging effects of lung disease in COVID-19 patients

Health workers warn loosening mask advice in hospitals would harm patients and providers

How did exposure to news on COVID-19 through social platforms impact psychological health and behavior?

Is the new bivalent COVID-19 vaccine the booster we've been waiting for?

How well do current vaccines hold up against new SARS-CoV-2 variants BA.2.86 and FLip?

Phase 3 study: The efficacy of monovalent SARS-CoV-2 vaccine with AS03 adjuvant in adults

Unlocking the power of lectins: BOA emerges as a potent weapon against all SARS-CoV-2 variants

Innovations in baculovirus–insect cell expression systems

Compound Management and its Crucial Role in Early Pharmaceutical Research

Natural products: the next frontier in drug discovery

Latest News